Study demonstrates the Bio-RFID™ sensor can deliver stable, repeatable results in predicting blood glucose concentrations using the Dexcom G6® as a reference device From December 2022 through February ...
CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS). This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary ...
Many regions have implemented newborn screening (NBS) for cystic fibrosis (CF) using a limited panel of cystic fibrosis transmembrane regulator (CFTR) mutations after immunoreactive trypsinogen (IRT) ...
VANCOUVER, BC, Dec. 2, 2025 /CNW/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla" or the "Company") has posted a replay of its recent webinar summarizing the positive results ...
Committee for a Study on the Feasibility of Wheelchair Restraint Systems in Passenger Aircraft TRB is convening the first committee meeting on February 5, 2020 to determine the feasibility of in-cabin ...
ST. GEORGE’S, NEWFOUNDLAND AND LABRADOR / ACCESS Newswire / November 6, 2025 / Atlas Salt Inc. (“Atlas Salt” or the “Company”) (TSXV:SALT)(OTCQB:REMRF)(FRA:9D00) announces that the Company has filed ...
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (TSX: MARI) (ASX: MC2) (“Marimaca” or the “Company”) announces it has filed the Feasibility Study technical report ...
Vizsla Silver is a Canadian mineral exploration and development company headquartered in Vancouver, BC, focused on advancing its flagship, 100%-owned Panuco silver-gold project located in Sinaloa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback